In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 pill to establish Protected dosing routine. Supplemental contributors will probably be enrolled for the identified monotherapy dosign regimen. In Segment B, individuals will get oral ruxolitinib and ABBV-744 will be presented as "include-on" therapy. In Section C, https://adolfa332pal5.blogginaway.com/profile